Related Experiment Video

Updated: Mar 6, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.9K

[The Role of Markers of Organ Damage in Patients With Chronic Heart Failure]

D E Koshkina1, A A Skvortsov1, V N Protasov1

  • 1Institute of Cardiology, Russian Cardiology Scientific and Production Complex, ul. Tretiya Cherepkovskaya 15a, 121552 Moscow, Russia.

Kardiologiia
|March 16, 2017
PubMed

Insights

This review examines high-sensitivity troponin T (hsTnT) and urinary neutrophil gelatinase-associated lipocalin (NGAL) as biomarkers for myocardial and renal damage in chronic heart failure (CHF) patients. It synthesizes current research on their diagnostic and prognostic roles.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarker Research

Context:

  • Chronic heart failure (CHF) is a complex condition with significant myocardial and renal implications.
  • Accurate assessment of organ damage is vital for effective CHF management.
  • Novel biomarkers offer potential for improved diagnostic and prognostic capabilities.

Purpose:

  • To review current research on high-sensitivity troponin T (hsTnT) for myocardial damage.
  • To review current research on urinary neutrophil gelatinase-associated lipocalin (NGAL) for renal damage.
  • To explore the combined role of hsTnT and NGAL in patients with CHF.

Summary:

  • This review synthesizes studies investigating hsTnT as a marker of cardiac injury.
  • It details the utility of urinary NGAL as an indicator of acute kidney injury in CHF.
  • The interplay between cardiac and renal biomarkers in CHF pathophysiology is discussed.

Impact:

  • Highlights the clinical significance of hsTnT and NGAL in CHF.
  • Provides insights into the dual organ involvement in heart failure.
  • Informs potential therapeutic strategies targeting myocardial and renal protection in CHF patients.

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

704

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
743
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
668
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.1K